Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 269 entries
View as:

Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT00422240 Org: User:
Start: 06/27/06 End: 07/12/07 Due: 07/12/08

Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01014689 Org: User:
Start: 08/31/09 End: 05/31/10 Due: 05/31/11

Phase 3 Papulopustular Rosacea Study

Phase: N/A Priority: Normal
NCT ID: NCT01493687 Org: User:
Start: 12/31/11 End: 08/31/13 Due: 08/31/14

Effect of CD07805/47 Gel in Rosacea Flushing

Phase: N/A Priority: Normal
NCT ID: NCT02300129 Org: User:
Start: 04/30/14 End: 06/30/14 Due: 06/30/15

Non-comparative Evaluation of Facial Expressions Following Lower Face Correction Using Emervel Classic and Emervel Deep

Phase: N/A Priority: Normal
NCT ID: NCT02672644 Org: User:
Start: 03/31/16 End: 05/31/16 Due: 05/31/17

Evaluate Effectiveness of Epiduo® Gel in Reducing Antibiotic Sensitive & Resistant Strains of Propionibacterium (P)Acnes

Phase: N/A Priority: Normal
NCT ID: NCT00907101 Org: User:
Start: 06/30/09 End: 07/31/09 Due: 07/31/10

A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients

Phase: N/A Priority: Normal
NCT ID: NCT06357221 Org: User:
Start: 04/08/24 End: 07/18/24 Due: 07/18/25

AkLief Evaluation in Acne-induced Post-Inflammatory Hyperpigmentation

Phase: N/A Priority: Normal
NCT ID: NCT05089708 Org: User:
Start: 12/22/21 End: 12/15/22 Due: 12/15/23

Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01320033 Org: User:
Start: 03/29/11 End: 01/03/12 Due: 01/03/13

Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea

Phase: N/A Priority: Normal
NCT ID: NCT01355458 Org: User:
Start: 05/31/11 End: 12/31/11 Due: 12/31/12

Evaluate Efficacy, Safety & Subject Satisfaction of Pain Management With Pliaglis® Cream for Dermal Filler Injections

Phase: N/A Priority: Normal
NCT ID: NCT00716443 Org: User:
Start: 07/31/08 End: 09/30/08 Due: 09/30/09

PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Call Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00472043 Org: User:
Start: 10/01/00 End: 09/30/02 Due: 09/30/03

Swedish Macrolane Registry

Phase: N/A Priority: Normal
NCT ID: NCT01145235 Org: User:
Start: 04/30/10 End: 01/31/19 Due: 01/31/20

Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne

Phase: N/A Priority: Normal
NCT ID: NCT02932267 Org: User:
Start: 02/02/17 End: 01/10/18 Due: 01/10/19

Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02125279 Org: User:
Start: 05/31/14 End: 05/31/18 Due: 05/31/19

A Safety and Efficacy Study of Different Injections Volumes of Botulinum Toxin Type A, Azzalure, in the Glabellar Lines

Phase: N/A Priority: Normal
NCT ID: NCT02108158 Org: User:
Start: 04/30/14 End: 12/31/14 Due: 12/31/15

Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01880320 Org: User:
Start: 07/31/13 End: 03/31/14 Due: 03/31/15

Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines

Phase: N/A Priority: Normal
NCT ID: NCT05148000 Org: User:
Start: 01/23/23 End: 06/23/23 Due: 06/23/24

Study to Evaluate Restylane Vital Light Using an Injector Device

Phase: N/A Priority: Normal
NCT ID: NCT01412190 Org: User:
Start: 04/30/09 End: 07/31/10 Due: 07/31/11

Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines

Phase: N/A Priority: Normal
NCT ID: NCT05146999 Org: User:
Start: 05/09/22 End: 09/01/23 Due: 09/01/24

Volume Restoration of Plantar Pad With a Hyaluronic Acid Dermal Filler in Metatarsalgia

Phase: N/A Priority: Normal
NCT ID: NCT02369380 Org: User:
Start: 11/30/14 End: 10/31/15 Due: 10/31/16

A Study to Evaluate the Performance and Safety of GP0045 for Correction of Moderate to Severe Nasolabial Folds

Phase: N/A Priority: Normal
NCT ID: NCT03300466 Org: User:
Start: 10/02/17 End: 04/24/19 Due: 04/24/20

Sculptra Chart Review

Phase: N/A Priority: Normal
NCT ID: NCT05463978 Org: User:
Start: 07/14/22 End: 10/14/22 Due: 10/14/23

A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab

Phase: N/A Priority: Normal
NCT ID: NCT04365387 Org: User:
Start: 03/05/20 End: 07/07/23 Due: 07/07/24

Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus a Two-course Treatment With Urea 40% Ointment and Bifonazole Cream 1%

Phase: N/A Priority: Normal
NCT ID: NCT02705664 Org: User:
Start: 01/31/16 End: 09/30/16 Due: 09/30/17